ARCHIVES

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

NCI, NSF fund awards in nanotech training.

September 23, 2005

DCT Board Approves Drug Development Recompetition

November 30, 1990

NCI CTEP Approved Trials For the Month of March

March 29, 2013

FCRF Program Proving Good Basic Research Can Be Supported By NCI With a Contract

January 23, 1987

NCI Proposes Consolidation of Nine Cooperative Groups to Four

December 17, 2010

Nurses Must Assist In Pain Management, ONS Says

May 31, 1991